Jubilant and Orion for joint manufacture of drugs

MUMBAI: Bangalore-based Jubilant Biosys and Noida-based Jubilant Chemsys have together signed an agreement with Finnish pharmaceutical company Orion for joint manufacture of drugs.

In a statement to the BSE, Jubilant Biosys and Jubilant Chemsys - subsidiaries of Jubilant Organosys - said Orion will have the option of using resources from both the companies.

"We are very pleased to partner with Orion and offer our integrated discovery services enabling the discovery efforts at Orion," said Jubilant Biosys CEO Sri Mosur. Jubilant's flexible and hybrid platform of innovative discovery chemistry, biology and insilico services demonstrates its ability to customise and accelerate global drug discovery efforts. It will be our continued endeavor to enable creative partnering models."

A team of scientists from Jubilant Biosys and Chemsys will do research on Orion's projects at the two subsidiaries. Antti Haapalinna, Vice President of Orion said: "We are confident of scaling up our drug discovery programmes with support from Jubilant's scientific team. Through this, we would achieve a good basis as it would complement our in-house discovery effort."